Dyslipidemia patterns and associated factors in Wilson's disease patients: a clinical analysis

被引:0
|
作者
Wu, Rong [1 ]
Luo, Xingguang [2 ]
Wang, Xiao-Ping [3 ]
机构
[1] Shanghai Jiao Tong Univ, TongRen Hosp, Sch Med, Dept Neurol, Shanghai, Peoples R China
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
[3] Shanghai Jiao Tong Univ, Renji Hosp, Sch Med, Shanghai, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
Wilson's disease; dyslipidemia; influencing factors; regression analysis; lipidemia metabolism; SPLENECTOMY; SPLEEN;
D O I
10.3389/fneur.2024.1411236
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective This study aims to analyze the lipid metabolism patterns and identify risk factors for dyslipidemia in Wilson's Disease (WD), offering novel insights into diagnosis and treatment strategies for unexplained dyslipidemia.Methods Data from Wilson's disease patients hospitalized at the First People's Hospital of Shanghai from December 2008 to February 2015 were collected. Patients were categorized into normal lipid (46 cases) and dyslipidemia (42 cases) groups based on lipid levels. Group analyzes were conducted using t-tests, chi-square analysis, and rank sum tests. Spearman correlation, multiple linear regression, or Logistic regression were employed to identify relevant influencing factors.Results 1. The incidence of abnormal blood lipids in a series of Wilson's disease patients was 47.73% (25.12 +/- 1.29 years old), and the incidence of control healthy group was 27.40%, with proportions of hypercholesterolemia, hypertriglyceridemia, and low-density lipoprotein cholesterol being 14.77, 30.68, and 29.63%, respectively; 2. Significant differences were observed between the dyslipidemia and normal WD groups in AST/ALT ratio, liver parenchymal echo, liver surface, spleen area, and ultrasound total score.3. Low-and high-density lipoprotein cholesterols (LDL-c and HDL-c) showed no significant correlation with these indicators. Triglyceride (TG) exhibited moderately negative correlation with AST/ALT, liver parenchymal echo, spleen area, and ultrasound score. Total cholesterol (TC) displayed low negative correlation with these factors.Conclusion 1. Dyslipidemia incidence in Wilson's disease patients may exceed that of the normal population, especially in adolescents with unexplained abnormal lipid metabolism; 2. Patients with mild to moderate liver damage are predisposed to elevated triglycerides and total cholesterol, reflecting liver damage impact on lipid metabolism; 3. Glucose metabolism is not implicated in WD-related dyslipidemia; 4. No significant correlation was found between abnormal lipid metabolism and blood concentration of trace elements in WD patients.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Characterization of the plasma proteins associated with Wilson's disease by proteome analysis
    Wang, P. W.
    Chao, David
    Pan, Tai-Long
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S231 - S231
  • [32] Families With Wilson's Disease in Subsequent Generations: Clinical and Genetic Analysis
    Dziezyc, Karolina
    Litwin, Tomasz
    Chabik, Grzegorz
    Gramza, Karolina
    Czlonkowska, Anna
    MOVEMENT DISORDERS, 2014, 29 (14) : 1828 - 1832
  • [33] Wilson's disease, clinical and molecular genetic analysis in Republic of Moldova
    Ciumas, M.
    Sacara, V. C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 300 - 301
  • [34] Comparative Analysis of Clinical and Laboratory Profile of Children with Wilson's Disease
    Bairwa, Naresh Kumar
    Bagri, Dhan Raj
    Sharma, J. N.
    INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (09): : 936 - 936
  • [35] Comparative Analysis of Clinical and Laboratory Profile of Children with Wilson’s Disease
    Naresh Kumar Bairwa
    Dhan Raj Bagri
    J. N. Sharma
    Indian Journal of Pediatrics, 2022, 89 : 936 - 936
  • [36] Clinical and Genetic Analysis in Neurological Wilson's Disease Patients With Neurological Worsening Following Chelator Therapy
    Hou, Haiman
    Chen, Dingbang
    Liu, Junxiu
    Feng, Li
    Zhang, Jiwei
    Liang, Xiuling
    Xu, Yuming
    Li, Xunhua
    FRONTIERS IN GENETICS, 2022, 13
  • [37] Clinical factors associated with anxiety in Parkinson's disease
    Nirenberg, M. J.
    Klufas, M. A.
    Boxhorn, C. E.
    Shih, A. Y.
    Tsankova, N. M.
    Henchcliffe, C.
    Thorne, J. T.
    MOVEMENT DISORDERS, 2008, 23 (01) : S287 - S288
  • [38] Wilson's disease: clinical spectrum of liver disease
    Ochoa Palominos, Alejandra
    Ibanez Samaniego, Luis
    Catalina Rodriguez, Maria-Vega
    Pajares Diaz, Jose
    Clemente Ricote, Gerardo
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (02): : 86 - 91
  • [39] DEMOGRAPHIC, CLINICAL AND GENETIC FACTORS ASSOCIATED WITH DYSBIOSIS IN PATIENTS WITH ACTIVE CROHN'S DISEASE
    Benjamin, J. L.
    Koutsoumpas, A.
    Hedin, C. R. H.
    Ng, S. C.
    Prescott, N. J.
    Pessoa-Lopes, P.
    Mathew, C. G.
    Kamm, M. A.
    Hart, A. L.
    Sanderson, J. D.
    Knight, S. C.
    Forbes, A.
    Stagg, A. J.
    Lindsay, J. O.
    Whelan, K.
    GUT, 2010, 59 : A5 - A5
  • [40] Clinical outcomes associated with pharmacist involvement in patients with dyslipidemia
    Cross, LB
    Franks, AS
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2005, 13 (01) : 31 - 42